Comparison between Allchem Lifescience IPO and Trualt Bioenergy IPO.
Allchem Lifescience IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Trualt Bioenergy IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Allchem Lifescience IPO is up to ₹0.00 Cr whereas the issue size of the Trualt Bioenergy IPO is up to ₹839.28 Cr. The final issue price of Allchem Lifescience IPO is and of Trualt Bioenergy IPO is ₹496.00 per share.
| Allchem Lifescience IPO | Trualt Bioenergy IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹472.00 per share | |
| Issue Price (Upper) | ₹496.00 per share | |
| Issue Price (Final) | ₹496.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 30 shares | |
| Fresh Issue Size | 0 shares | 1,51,20,967 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹750.00 Cr |
| OFS Issue Size | 71,55,000 shares | 18,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹89.28 Cr |
| Issue Size Total | 0 shares | 1,69,20,967 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹839.28 Cr |
Allchem Lifescience IPO opens on , while Trualt Bioenergy IPO opens on Sep 25, 2025. The closing date of Allchem Lifescience IPO and Trualt Bioenergy IPO is , and Sep 29, 2025, respectively.
| Allchem Lifescience IPO | Trualt Bioenergy IPO | |
|---|---|---|
| Anchor Bid Date | Sep 24, 2025 | |
| Issue Open | Sep 25, 2025 | |
| Issue Close | Sep 29, 2025 | |
| Basis Of Allotment (Tentative) | Sep 30, 2025 | |
| Initiation of Refunds (Tentative) | Oct 01, 2025 | |
| Credit of Share (Tentative) | Oct 01, 2025 | |
| Listing date (Tentative) | Oct 03, 2025 | |
| Anchor Lockin End date 1 | Oct 29, 2025 | |
| Anchor Lockin End date 2 | Dec 28, 2025 |
Allchem Lifescience IPO P/E ratio is , as compared to Trualt Bioenergy IPO P/E ratio of 23.89.
| Allchem Lifescience IPO | Trualt Bioenergy IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)Trualt Bioenergy Ltd.'s revenue increased by 54% and profit after tax (PAT) rose by 361% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 88.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 23.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹4253.33 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.33% | 28.27% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 22.87% | 10.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.31 | 2.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.06 | ₹20.76 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 34.33% | 19.07% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Allchem Lifescience IPO Retail Individual Investors (RII) are offered while in Trualt Bioenergy IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Allchem Lifescience IPO and 33,84,193 shares in Trualt Bioenergy IPO.
| Allchem Lifescience IPO | Trualt Bioenergy IPO | |
|---|---|---|
| Anchor Investor Reservation | 50,76,289 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 33,84,193 shares | |
| NII | 25,38,146 shares | |
| RII | 59,22,339 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 1,69,20,967 shares |
Allchem Lifescience IPO subscribed in total, whereas Trualt Bioenergy IPO subscribed 75.02x.
| Allchem Lifescience IPO | Trualt Bioenergy IPO | |
|---|---|---|
| QIB (times) | 165.16x | |
| NII (times) | 103.04x | |
| Big NII (times) | 118.62x | |
| Small NII (times) | 71.87x | |
| RII (times) | 11.50x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 75.02x |
